CASI Pharmaceuticals Inc Earnings

The next earnings date for CASI Pharmaceuticals Inc has not yet been scheduled.

Analyst Estimates of CASI Pharmaceuticals Inc Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

CASI Pharmaceuticals Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/12/2025Before Market$-0.93---
03/26/2025Before Market------
11/14/2024Before Market$-0.5511.47%
08/16/2024Before Market$-0.5512.70%
05/14/2024Before Market$-0.71-1,320.00%
03/28/2024Before Market$-0.45-87.50%
11/14/2023Before Market$-0.3537.50%
08/11/2023Before Market$-0.77-54.00%
05/17/2023Before Market$-0.4529.69%
03/30/2023Before Market$-1.44-289.19%
11/14/2022Before Market$-0.3817.39%
08/12/2022Before Market$-0.5612.50%
05/12/2022Before Market$-0.6031.03%
03/28/2022Before Market$-0.4029.82%
11/12/2021Before Market$-0.70-27.27%
08/12/2021Before Market$-0.5030.56%
05/13/2021Before Market$-1.10-83.33%
03/30/2021Before Market$-1.20-71.43%
11/09/2020Before Market$-1.40-154.55%
08/10/2020Before Market$-0.7012.50%
05/11/2020Before Market$-0.9018.18%
03/16/2020Before Market$-1.20-9.09%
11/12/2019Before Market$-19.09%
08/09/2019Before Market$-1.60-77.78%
05/15/2019Before Market$-0.900.00%
03/29/2019Before Market$-1-25.00%
11/14/2018After Market$-0.10-150.00%
08/14/2018Before Market$-0.700.00%
05/15/2018Before Market$-0.5028.57%
03/29/2018Before Market$-0.80-300.00%
11/14/2017Before Market$-0.3025.00%
08/14/2017Before Market$-0.040.00%
05/15/2017Before Market$-0.0325.00%
03/31/2017Before Market$-0.5028.57%
11/14/2016Before Market$-0.3062.50%
08/15/2016Before Market$-0.80-100.00%
05/13/2016Before Market$-0.4020.00%
03/28/2016Before Market$-0.50-66.67%
11/13/2015Before Market$-0.5028.57%
08/14/2015Before Market$-0.600.00%
05/15/2015After Market$-0.06---
03/27/2015After Market$-0.05---
11/14/2014After Market$-0.77---
08/14/2014After Market$-0.06---
05/15/2014---$-0.54---
03/21/2014---$-0.48---
11/14/2013---$-0.53---
08/14/2013---$-0.69---
05/15/2013---$-0.49---
03/21/2013---$-0.16---
11/12/2012---$-0.53---
08/13/2012---$-5.56---
05/15/2012---$-2.29---
03/09/2012---$0.64---
11/14/2011---$-1.30---
08/15/2011---$-1.66---
05/16/2011---$-2.49---
03/30/2011---$0.84---
11/15/2010---$-2.42---
08/16/2010---$-6.24---
05/18/2010---$-2.82---
03/30/2010---$-3.30---
11/16/2009---$-0.21---
08/06/2009---$-4.14---
05/06/2009---$-4.72---
03/12/2009---$-3.51---
11/06/2008---$-4.4020.00%
08/06/2008---$-12.63---
05/02/2008---$-110.00%
03/06/2008---$-5.50-25.00%
11/06/2007---$-4.4042.86%
08/08/2007---$-110.00%
05/09/2007---$-9.9025.00%
03/13/2007---$-8.80-33.33%
11/06/2006---$-5.5037.50%
08/09/2006---$-9.9010.00%
05/10/2006---$-58.30-430.00%
03/07/2006---$-5.50-66.67%
11/03/2005---$-9.90-80.00%
07/28/2005---$-9.9030.77%
05/03/2005---$-14.30-8.33%
03/09/2005---$-2.2033.33%
11/09/2004---$-10.09---
08/03/2004---$-13.2020.00%
04/27/2004---$-15.40-7.69%
02/20/2004---$-19.80-50.00%
11/06/2003---$-16.500.00%
07/30/2003---$-21.20---
05/14/2003---$-17.77---
03/04/2003---$-7.7066.67%
11/14/2002---$-59.40-5.88%
08/14/2002---$-56.1022.73%
05/15/2002---$-73.702.19%
03/05/2002---$-141.90-59.26%
11/07/2001---$36.30148.77%
08/09/2001---$-90.20-31.54%
05/10/2001---$-68.2013.29%
03/30/2001---$-90.2013.68%
10/31/2000---$-72.6012.00%
08/09/2000---$-92.40-24.44%
05/10/2000---$-79.200.00%
03/22/2000---$-111.10-48.53%
11/12/1999---$-52.8015.79%
08/11/1999---$-67.10-121.82%
05/24/1999---$-60.50-107.55%
03/01/1999---$-38.50-31.58%
10/27/1998---$-34.10-19.23%
08/10/1998---$-16.5033.33%
05/18/1998---$-27.50-8.70%
03/31/1998---$-18.700.00%
11/13/1997---$-16.5021.05%
08/18/1997---$-1144.44%
05/13/1997---$-13.2029.41%
03/24/1997---$-1141.18%
11/18/1996---$-12.1042.11%

More About CASI Pharmaceuticals Inc

Website
https://www.casipharmaceuticals.com
Country
USA
Full Time Employees
233

CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People's Republic of China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation and as a palliative treatment for patients with multiple myeloma. The company's hematology/oncology assets in pipeline include CNCT19, an autologous CD19 CAR-T investigative product; BI-1206, an novel anti-Fc"RIIB antibody for the treatment of solid tumors and relapsed/refractory non-hodgkin lymphoma; CB-5339, a novel VCP/p97 inhibitor that focuses on valosin-containing protein (VCP)/p97 as a novel target in protein homeostasis, DNA damage response, and other cellular stress pathways for therapeutic use in the treatment of patients with various malignancies; CID-103, a human IgG1 anti-CD38 monoclonal antibody; and Thiotepa, a chemotherapeutic agent, which has various indications, including use as a conditioning treatment for use prior to certain allogeneic haemopoietic stem cell transplants. It has licensing agreements with Juventas Cell Therapy Ltd.; BioInvent International AB; Black Belt Therapeutics Limited; Cleave Therapeutics, Inc.; and Acrotech Biopharma L.L.C. to develop and commercialize its commercial product EVOMELA. CASI Pharmaceuticals, Inc. was incorporated in 1991 and is based in Beijing, the People's Republic of China.

“CASI Pharmaceuticals Inc Earnings” Can Refer to the CASI Pharmaceuticals Inc Earnings Date

Some people say “CASI Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my CASI Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning CASI Pharmaceuticals Inc Stock on the Earnings Date

If you own CASI Pharmaceuticals Inc stock (CASI) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for CASI Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading CASI Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More CASI Pharmaceuticals Inc Earnings

You can contact us any time if you would like to ask questions about CASI Pharmaceuticals Inc earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.